Cumberland Partners LTD Astrazeneca PLC Transaction History
Cumberland Partners LTD
- $1.33 Billion
- Q4 2024
A detailed history of Cumberland Partners LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Cumberland Partners LTD holds 4,611 shares of AZN stock, worth $348,822. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,611
Previous 4,398
4.84%
Holding current value
$348,822
Previous $342,000
11.7%
% of portfolio
0.02%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.57 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.1 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.84 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.8 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.82 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...